MedPath

Clinical study of snake antipruritic pills in the treatment of chronic spontaneous urticaria

Phase 4
Conditions
Chronic spontaneous urticaria
Registration Number
ITMCTR2200005651
Lead Sponsor
guangdong Provincial Hospital of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the criteria for diagnosis of chronic spontaneous urticaria: spontaneous wind mass and/or angioedema onset > 6 weeks (Chinese urticaria diagnosis and treatment guide 2018); 2. Age: 18-65 years old, gender-neutral; The degree of itching is light to medium level: light grade is itchy, not obvious (1 point); The number of wind groups is light and medium: light is the number of wind groups< 20 /24h (1 point); Agree to participate in this clinical trial and sign an informed consent form.

Exclusion Criteria

1. Induced urticaria patients (physical: artificial urticaria (skin scratch), cold-contact urticaria, delayed pressure urticaria, hot-contact urticaria, solar urticaria, vibrating angioedema, choline-energy urticaria; nonphysical: water-source urticaria, contact urticaria); 2. Patients with other diseases that can cause itching; Patients with other life-threatening severe systemic symptoms such as co-infection and throat edema; Combined with serious cardiovascular, liver, kidney and other important organs of internal medicine diseases; 5. Communication barriers, people with mental and mental illness; People who have received glucocorticoids, immunosuppressants, etc. within 3 months; 1 month has used Chinese medicine, acupuncture and other treatment of urticaria; 8. Those who have taken quinoa, pentaphospharide, soap or its preparations within 1 month; Those who have a history of allergies to the active ingredients or preparation aids of the ooselta, or have a history of allergies to other foods or drugs; Patients with pregnancy, lactation or recent birth plans; Need high-altitude operators; 12. Participants in clinical trials of other medical facilities or drugs within 3 months; The researchers did not consider it appropriate for participants.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The score of itching degree was improved on 7 days(ISS7)(28 days)));
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath